Since some of the patients with Leigh syndrome may develop stroke-like episodes (SLEs) (Morin et al. 1999 ), a typical manifestation of MELAS syndrome, we should be informed if neuropathological investigations of the 20 animals showed features of a stroke-like lesion in any of them. The stroke-like lesion is the morphological equivalent of a SLE on imaging, characterised by a vasogenic edema not confined to vascular territory. Stroke-like lesions typically show dynamic increases and regressions over time.
Occasionally, extra-cerebral manifestations can be found in human Leigh syndrome (Finsterer 2008) . These include polyneuropathy, myopathy, diabetes, short stature, cardiomyopathy, anemia, renal insufficiency, diarrhoea, or hypertrichosis (Finsterer 2008 ). Thus, we should know if any of the 20 animals undergoing FOXRED1 silencing developed any of these extra-cerebral manifestations. Particularly affected organs in Leigh syndrome are the heart, the muscle the peripheral nerves, and the endocrine organs, why we should be informed if there were any indications for cardiomyopathy, arrhythmias, endocrine abnormalities, myopathy or neuropathy.
In summary, we do not agree with the conclusions that the data provided justify to regard C57b1/6 mice undergoing FOXRED1 silencing as an animal model of Leigh syndrome. The value of an animal model is high if genotypic and phenotypic characteristics of the animal and human are closely similar.
